Skip to main content
. 2010 Sep 26;78(4):941–957. doi: 10.3797/scipharm.1004-24

Fig. 5.

Fig. 5.

In vitro antibacterial activity of drug solution and formulation (GS5) against E. coli. [Values reported as mean ± SD (n = 3); * Significantly different (p < 0.001)]